Apellis Pharmaceuticals
APLS
$25.02
Share price
-1.86%
Change (1 day)
-64.28%
Change (1 year)
Categories
Revenue for Apellis Pharmaceuticals (APLS)
Revenue in 2024 (TTM): S$1.04 Billion
According to Apellis Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is S$1.03 Billion. an increase over the revenue in the year 2023 that were of S$0.52 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Apellis Pharmaceuticals from 2017 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | S$1.06 B | 102.77% |
| 2023 | S$0.52 B | 418.02% |
| 2022 | S$0.10 B | 12.36% |
| 2021 | S$89.98 M | -72.86% |
| 2020 | S$0.33 B | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |